Search Results - "EKINS, S"

Refine Results
  1. 1

    In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling by Ekins, S, Mestres, J, Testa, B

    Published in British journal of pharmacology (01-09-2007)
    “…Pharmacology over the past 100 years has had a rich tradition of scientists with the ability to form qualitative or semi‐quantitative relations between…”
    Get full text
    Journal Article
  2. 2

    In silico pharmacology for drug discovery: applications to targets and beyond by Ekins, S, Mestres, J, Testa, B

    Published in British journal of pharmacology (01-09-2007)
    “…Computational (in silico) methods have been developed and widely applied to pharmacology hypothesis development and testing. These in silico methods include…”
    Get full text
    Journal Article
  3. 3

    Predicting undesirable drug interactions with promiscuous proteins in silico by Ekins, Sean

    Published in Drug Discovery Today (15-03-2004)
    “…Although computational tools have been used to predict toxic responses resulting from molecules binding either as substrates or inhibitors to proteins, there…”
    Get full text
    Book Review Journal Article
  4. 4

    In silico approaches to predicting drug metabolism, toxicology and beyond by Ekins, S

    Published in Biochemical Society transactions (01-06-2003)
    “…The discovery and optimization of new drug candidates is becoming increasingly reliant upon the combination of experimental and computational approaches…”
    Get more information
    Journal Article
  5. 5

    Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays by Petrie, M., Lynch, K. L., Ekins, S., Chang, J. S., Goetz, R. J., Wu, A. H. B., Krasowski, M. D.

    Published in Clinical toxicology (Philadelphia, Pa.) (01-02-2013)
    “…Introduction. The increasing abuse of amphetamine-like compounds presents a challenge for clinicians and clinical laboratories. Although these compounds may be…”
    Get full text
    Journal Article
  6. 6

    Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel by Ekins, Sean, Crumb, William J, Sarazan, R Dustan, Wikel, James H, Wrighton, Steven A

    “…The protein product of the human ether-a-go-go gene (hERG) is a potassium channel that when inhibited by some drugs may lead to cardiac arrhythmia. Previously,…”
    Get more information
    Journal Article
  7. 7

    Computational Modeling to Accelerate the Identification of Substrates and Inhibitors for Transporters That Affect Drug Disposition by Ekins, S, Polli, J E, Swaan, P W, Wright, S H

    Published in Clinical pharmacology and therapeutics (01-11-2012)
    “…We have seen an increased use of computational approaches to predicting drug interactions with human transporters that affect drug disposition and may lead to…”
    Get full text
    Journal Article
  8. 8

    A Pharmacophore for Human Pregnane X Receptor Ligands by EKINS, Sean, ERICKSON, Jon A

    Published in Drug metabolism and disposition (01-01-2002)
    “…The pregnane X receptor (PXR) is involved in transcriptional regulation of multiple cytochromes P450 and multidrug resistance-associated protein (MDR1), which…”
    Get full text
    Journal Article
  9. 9

    Future directions for drug transporter modelling by Ekins, S., Ecker, G. F., Chiba, P., Swaan, P. W.

    Published in Xenobiotica (01-10-2007)
    “…Since the late 1980s computational methods such as quantitative structure-activity relationship (QSAR) and pharmacophore approaches have become more widely…”
    Get full text
    Journal Article
  10. 10

    Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms by Ekins, S., Bugrim, A., Brovold, L., Kirillov, E., Nikolsky, Y., Rakhmatulin, E., Sorokina, S., Ryabov, A., Serebryiskaya, T., Melnikov, A., Metz, J., Nikolskaya, T.

    Published in Xenobiotica (01-10-2006)
    “…The authors have previously applied two integrated platforms, MetaCore™ and MetaDrug™, for the assembly and analysis of human biological networks as a useful…”
    Get full text
    Journal Article
  11. 11

    A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians by McLay, J S, Tanaka, M, Ekins-Daukes, S, Helms, P J

    Published in Archives of disease in childhood (01-07-2006)
    “…Objective: To assess current attitudes of hospital based paediatricians to off label prescribing, and the performance of clinical trials in children. Design: A…”
    Get full text
    Journal Article
  12. 12
  13. 13

    PXR and the regulation of apoA1 and HDL-cholesterol in rodents by Bachmann, Kenneth, Patel, Hiral, Batayneh, Zaid, Slama, James, White, Donald, Posey, Julie, Ekins, Sean, Gold, David, Sambucetti, Lidia

    Published in Pharmacological research (01-09-2004)
    “…Orphan nuclear receptors (ONRs) have been implicated in the regulation of lipids. Several clinical studies conducted either prospectively or epidemiologically…”
    Get full text
    Journal Article
  14. 14

    Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates by Ekins, S, Bravi, G, Wikel, J H, Wrighton, S A

    “…To gain a better understanding of the active site of cytochrome P-450 (CYP) 3A4, a three-dimensional-quantitative structure activity relationship model was…”
    Get more information
    Journal Article
  15. 15

    Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance by Ekins, S, Obach, R S

    “…Future alternatives to the presently accepted in vitro paradigm of prediction of intrinsic clearance, which could be used earlier in the drug discovery…”
    Get more information
    Journal Article
  16. 16

    Three- and Four-Dimensional-Quantitative Structure Activity Relationship (3D/4D-QSAR) Analyses of CYP2C9 Inhibitors by EKINS, S, BRAVI, G, BINKLEY, S, GILLESPIE, J. S, RING, B. J, WIKEL, J. H, WRIGHTON, S. A

    Published in Drug metabolism and disposition (01-08-2000)
    “…The interaction of competitive type inhibitors with the active site of cytochrome P450 (CYP) 2C9 has been predicted using three- and four-dimensional…”
    Get full text
    Journal Article
  17. 17

    Improving the drug selection and development process for combination devices by Hupcey, Maggie A.Z., Ekins, Sean

    Published in Drug discovery today (01-10-2007)
    “…Combination devices are at the interface of both pharmaceutical and medical device research. While there have been several notable successes in bringing…”
    Get full text
    Journal Article
  18. 18

    Treatment Patterns and Asthma Control Among US Allergy and Pulmonary Community Practices: Results of the CHARIOT Study by Marcus, P, Arnold, R.J.G, Ekins, S, Sacco, P, Massanari, M, Donohue, J, Bukstein, D

    Published in Journal of allergy and clinical immunology (01-02-2008)
    “…A high proportion of these patients have atopic characteristics. [...]the role of allergies should be assessed and alternative treatment options, as stated in…”
    Get full text
    Journal Article
  19. 19

    Short-term maintenance of phase I and II metabolism in precision-cut liver slices in dynamic organ culture by Ekins, S

    Published in Drug metabolism and disposition (01-03-1996)
    “…Testosterone and 7-ethoxycoumarin were used as substrates to quantify the maintenance of phase I and II enzymes in precision-cut rat liver slices in dynamic…”
    Get more information
    Journal Article
  20. 20

    Autoactivation and activation of the cytochrome P450s by Ekins, S, Ring, B J, Binkley, S N, Hall, S D, Wrighton, S A

    “…In order to reliably predict in vivo pharmacokinetic parameters from in vitro data, we must thoroughly understand the systems we currently use to determine…”
    Get more information
    Journal Article